Lipoprotein_little_a.php

Lipoprotein (a) Test

The Lipoprotein (a) Test [also known as Lipoprotein Little a, Lp Little a and Lp(a)] is now recommended in several patient subgroups for whom excess lipoprotein (a) may have important clinical consequences:

Patients with premature atherosclerosis
Patients with a strong family history of premature coronary heart disease (CHD)
Patients with elevated LDLC and greater than or equal to two risk factors
Patients who have had coronary angioplasty in whom lipoprotein (a) excess may increase the risk of restenosis, and
Patients who have undergone coronary bypass graft surgery in whom Lp(a) excess may be associated with graft stenosis.

Lipoprotein (a) has been called a powerful predictor of premature atherosclerotic vascular disease. As an independent risk factor for premature coronary artery disease, excess Lp(a) concentrations are associated with an increased risk of cardiac death in patients with acute coronary syndromes and with restenosis after angioplasty (PTCA) and coronary bypass procedures. In general, concentrations >30 mg/dL of Lp(a) in serum are associated with a two- to six-fold increase in risk, depending on the presence of other risk factors.

A significant deviation from the normal range may require further evaluation by your physician.

Private MD Lab Services offers the following test for lipoprotein (a):

Lipoprotein (a) Test $44.49	Add To Cart

Heart Disease Risk Assessment

See for yourself the critical role cholesterol blood levels play in heart health! Use our interactive calculator to determine your 10-year risk of developing heart disease.

Launch Calculator